Sonoma Pharmaceuticals (SNOA) Debt to Equity: 2011-2012
Historic Debt to Equity for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Dec 2012 value amounting to $0.50.
- Sonoma Pharmaceuticals' Debt to Equity fell 97.49% to $0.50 in Q4 2012 from the same period last year, while for Dec 2012 it was $0.50, marking a year-over-year decrease of 99.28%. This contributed to the annual value of -$3.73 for FY2012, which is 349.41% down from last year.
- Per Sonoma Pharmaceuticals' latest filing, its Debt to Equity stood at $0.50 for Q4 2012, which was up 109.44% from -$5.28 recorded in Q3 2012.
- In the past 5 years, Sonoma Pharmaceuticals' Debt to Equity registered a high of $19.84 during Q4 2011, and its lowest value of -$18.77 during Q3 2011.
- Over the past 2 years, Sonoma Pharmaceuticals' median Debt to Equity value was $1.00 (recorded in 2012), while the average stood at $1.26.
- Data for Sonoma Pharmaceuticals' Debt to Equity shows a peak YoY increase of 71.89% (in 2012) and a maximum YoY decrease of 349.41% (in 2012) over the last 5 years.
- Quarterly analysis of 2 years shows Sonoma Pharmaceuticals' Debt to Equity stood at $19.84 in 2011, then crashed by 97.49% to $0.50 in 2012.
- Its Debt to Equity stands at $0.50 for Q4 2012, versus -$5.28 for Q3 2012 and $8.55 for Q2 2012.